(Total Views: 85)
Posted On: 07/18/2023 8:15:46 AM
Post# of 25481

$APVO News Article - Aptevo Announces Positive Duration of Remission Data from Phase 1b Expansion Trial Evaluating the Bispecific APVO436 for AML https://marketwirenews.com/news-releases/apte...17866.html


My Twitter: WhyteStocks